AU Patent

AU2015203404A1 — DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Assigned to Chrysalis Pharma AG · Expires 2015-07-16 · 11y expired

What this patent protects

H:\rec\Intrwovn\NRPortbl\DCC\REC\7744729_I.docx-1/05/2015 DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented.

USPTO Abstract

H:\rec\Intrwovn\NRPortbl\DCC\REC\7744729_I.docx-1/05/2015 DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015203404A1
Jurisdiction
AU
Classification
—
Expires
2015-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Chrysalis Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.